LifePoint Health (LPNT) Tops Q2 EPS by 13c, Miss on Revenues; Offers Soft FY17 EPS/Revenue Outlook

LifePoint Health (NASDAQ: LPNT) reported Q2 EPS of $1.03, $0.13 better than the analyst estimate of $0.90. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.64 billion.

GUIDANCE:

LifePoint Health sees FY2017 EPS of $3.92-$4.20, versus the consensus of $4.19. LifePoint Health sees FY2017 revenue of $6.425-6.5 billion, versus the consensus of $6.55 billion.

For earnings history and earnings-related data on LifePoint Health (LPNT) click here.

You May Also Be Interested In

• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
• Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance